Resurrect Bio raises €7.3M Series A round
17 February 2026· London, United Kingdom· health, agriculture, biotech, ai, b2b, deep_hardware
The funds will enable Resurrect Bio to accelerate its high-throughput trait discovery platform and advance multiple disease resistance products toward commercial partnerships.
Investors
LeadCorteva Agriscience
Also participating
AgFunderCalculus CapitalPymwymicSynBioVenUK Innovation & Science Seed Fund
About Resurrect Bio
Stage
Series A
Headquarters
London, United Kingdom
Founded
2021
Team Size
6–20
Sectors
healthagriculturebiotechaib2bdeep_hardware
Source: https://www.tsl.ac.uk/news/resurrect-bio-celebrates-8-1m-initial-close-of-series-a